Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Taura, Manabu
Eguma, Ayaka
Suico, Mary Ann
Shuto, Tsuyoshi
Koga, Tomoaki
Komatsu, Kensei
Komune, Takefumi
Sato, Takashi
Saya, Hideyuki
Li, Jian-Dong
and
Kai, Hirofumi
2008.
p53 Regulates Toll-Like Receptor 3 Expression and Function in Human Epithelial Cell Lines.
Molecular and Cellular Biology,
Vol. 28,
Issue. 21,
p.
6557.
Wu, Josephine
Sharaan, Mona
and
Zhang, David Y.
2008.
Molecular Genetic Pathology.
p.
533.
Zuure, Freke
Hahné, Susan
van de Laar, Thijs
Prins, Maria
and
van Steenbergen, Jim
2009.
Modern Infectious Disease Epidemiology.
p.
333.
Attallah, Abdelfattah M.
Shiha, Gamal E.
Ismail, Hisham
Mansy, Seham E.
El-Sherbiny, Rania
and
El-Dosoky, Ibrahim
2009.
Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Clinical Biochemistry,
Vol. 42,
Issue. 6,
p.
455.
Wang, Yu
Lu, Yiwei
Toh, Soo Ting
Sung, Wing-Kin
Tan, Patrick
Chow, Pierce
Chung, Alexander Y.F.
Jooi, London L.P.
and
Lee, Caroline G.L.
2010.
Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
Journal of Hepatology,
Vol. 53,
Issue. 1,
p.
57.
Fowell, Andrew J.
and
Nash, Kathryn L.
2010.
Telaprevir: a new hope in the treatment of chronic hepatitis C?.
Advances in Therapy,
Vol. 27,
Issue. 8,
p.
512.
Ishida, Hisashi
Tatsumi, Tomohide
Hosui, Atsushi
Nawa, Takatoshi
Kodama, Takahiro
Shimizu, Satoshi
Hikita, Hayato
Hiramatsu, Naoki
Kanto, Tatsuya
Hayashi, Norio
and
Takehara, Tetsuo
2011.
Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
Biochemical and Biophysical Research Communications,
Vol. 412,
Issue. 1,
p.
92.
Sautto, Giuseppe
Mancini, Nicasio
Solforosi, Laura
Diotti, Roberta A.
Clementi, Massimo
and
Burioni, Roberto
2012.
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role.
Clinical and Developmental Immunology,
Vol. 2012,
Issue. ,
p.
1.
Ye, Fei
Cui, Miao
Khasawneh, Rame H.
Shibata, Robert
Wu, Josephine
Sharaan, Mona
and
Zhang, David Y.
2013.
Molecular Genetic Pathology.
p.
655.
Casey, Lisa C.
and
Lee, William M.
2013.
Hepatitis C virus therapy update 2013.
Current Opinion in Gastroenterology,
p.
1.
LONG, JIANG
WANG, YAN
LI, MAN
TONG, WEI-MIN
JIA, JI-DONG
and
HUANG, JIAN
2013.
Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Oncology Reports,
Vol. 30,
Issue. 1,
p.
119.
Tahir, Mir
Rehman, Muneeb U
Lateef, Abdul
Khan, Abdul Quaiyoom
Khan, Rehan
Qamar, Wajhul
O’Hamiza, Oday
Ali, Farrah
Hasan, Syed Kazim
and
Sultana, Sarwat
2013.
Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model.
Toxicology Letters,
Vol. 220,
Issue. 3,
p.
205.
Belema, Makonen
Lopez, Omar D.
Bender, John A.
Romine, Jeffrey L.
St. Laurent, Denis R.
Langley, David R.
Lemm, Julie A.
O’Boyle, Donald R.
Sun, Jin-Hua
Wang, Chunfu
Fridell, Robert A.
and
Meanwell, Nicholas A.
2014.
Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors.
Journal of Medicinal Chemistry,
Vol. 57,
Issue. 5,
p.
1643.
Simos, Thomas
Georgopoulou, Urania
Thyphronitis, George
Koskinas, John
and
Papaloukas, Costas
2015.
Analysis of Protein Interaction Networks for the Detection of Candidate Hepatitis B and C Biomarkers.
IEEE Journal of Biomedical and Health Informatics,
Vol. 19,
Issue. 1,
p.
181.
Ortega, Juliana F.
de Conti, Aline
Tryndyak, Volodymyr
Furtado, Kelly S.
Heidor, Renato
Horst, Maria Aderuza
Fernandes, Laura Helena Gasparini
Tavares, Paulo Eduardo Latorre Martins
Pogribna, Marta
Shpyleva, Svitlana
Beland, Frederick A.
Pogribny, Igor P.
and
Moreno, Fernando Salvador
2016.
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
Oncotarget,
Vol. 7,
Issue. 17,
p.
24339.
Straub, Katja
Husen, Peri
Baba, Hideo A.
Trippler, Martin
Wedemeyer, Heiner
and
Herzer, Kerstin
2019.
Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice.
Cancer Medicine,
Vol. 8,
Issue. 8,
p.
3793.
Ahmed, Osama M.
Saleh, Ablaa S.
Ahmed, Eman A.
Ghoneim, Mohammed M.
Ebrahim, Hasnaa Ali
Abdelgawad, Mohamed A.
and
Abdel-Gabbar, Mohammed
2023.
Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats.
Pharmaceuticals,
Vol. 16,
Issue. 6,
p.
859.
Choudhary, Heena B
Mandlik, Satish K
and
Mandlik, Deepa S
2023.
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.
World Journal of Gastrointestinal Pathophysiology,
Vol. 14,
Issue. 3,
p.
46.